Leonid I Katolik MD

Physicians & Surgeons, Physicians & Surgeons, Dermatology, Physicians & Surgeons, Hand Surgery

Be the first to review!

Add Hours

(484) 454-5861Call

Add Website

Map & DirectionsDirections2010 W Chester PikeHavertown, PA 19083 Write a ReviewWrite Review

Accepted Insurance

Leonid I Katolik MD has not yet specified accepted insurance plans.

Specialties

Leonid I Katolik MD has not yet specified any specialties.

More Info

Payment method: insurance
AKA: Katolik Leonid I
Categories: Physicians & Surgeons, Physicians & Surgeons, Dermatology, Physicians & Surgeons, Hand Surgery, Physicians & Surgeons, Oncology, Physicians & Surgeons, Radiology, Physicians & Surgeons, Sexual Dysfunction

Gallery

Be the first to add a photo!

Reviews

Hi there!
Be the first to review!

Click to Rate

Details

Phone: (484) 454-5861

Address: 2010 W Chester Pike, Havertown, PA 19083

People Also Viewed

View similar Physicians & Surgeons

Suggest an Edit

Leonid I Katolik MD

General Practitioners

Erectile Dysfunction

Prostate Cancer
The American Cancer Society (ACS) recommends that men have a chance to make an informed decision with their health care provider about whether to be screened for prostate cancer. The decision should be made after getting information about the uncertainties, risks, and potential benefits of prostate cancer screening. Men should not be screened unless they have received this information. Men who want to be screened should be tested with the prostate-specific antigen (PSA) blood test.
Cancer Care
Philadelphia CyberKnife announced that board-certified radiation oncologist Anthony Ricco, M.D. has joined their cancer care treatment team. Dr. Ricco, a native of the greater Philadelphia area, graduated with a Bachelor of Science with Distinction from The Pennsylvania State University in State College, Pennsylvania, and received his medical doctorate from Sidney Kimmel Medical College at Thomas…
Lung Cancer
A screening is looking for a disease before a person has any symptoms, which can help to and lung cancer in an early, more treatable stage. Based on research, if a group of 1000 people were screened once a year for 3 years, 3 fewer people in 1000 would die of lung cancer after 6 years. This means that, instead of 21 people, 18 people per 1000 would die of lung cancer.

Radiology
Philadelphia CyberKnife recently had two posters presented at the American Society for Therapeutic Radiology and Oncology’s annual meeting from October 18 – 21 in San Antonio, TX. The American Society for Therapeutic Radiology and Oncology (ASTRO) is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. Radiation oncologists, medical physicists,…
X-Rays
Computed Tomography
Prior to treatment, doctors implant between three to five small metal markers known as fiducials in or near the tumor that enable the CyberKnife to pinpoint the tumor location throughout treatment. Implanting the markers is an outpatient procedure that takes about an hour. About a week later, patients are fitted with a custom body mold made of soft material that they lie on during treatments. The fitting process is painless. Patients then undergo a CT scan that assists in developing a customized treatment plan.
Chemotherapy
The most common sources of metastases in the brain include lung, breast, and skin cancers, though almost any cancer has the ability to spread to the brain. Chemotherapy is not effective for treating metastatic brain tumors. Radiosurgery is. Unlike most radiosurgery systems, the CyberKnife doesn’t need an invasive head frame. Other radiosurgery systems are capable of high-dose radiation treatment. However, nearly all methods use a metal frame attached to the patient’s skull with screws that immobilize the head to accurately target the tumor. Local anesthetic is used for mounting the frames, though frames can be uncomfortable and painful to some extent. The CyberKnife allows patients to receive a high dose of radiation in more than one treatment. Other systems do not. Known as fractionated radiosurgery, this method is particularly beneficial for patients who have previously received radiation therapy, as well as those with tumors near critical areas of the brain. CyberKnife radiosurgery delivers high-dose radiation while minimizing exposure to healthy tissue by precisely aiming multiple beams of radiation from many different angles. Therefore, radiosurgery is one the most aggressive and effective radiation treatments available for brain metastases. While whole-brain radiation therapy can require numerous treatments over several weeks, Cyberknife radiosurgery is usually completed one to five sessions and only treats the tumor(s), not the whole brain. CyberKnife radiosurgery also is used frequently for patients with more than one metastatic tumor, a condition that usually prevents surgery. CyberKnife can also be used after surgery to prevent regrowth or to treat a tumor that persists or regrows after surgery.
Radiation Therapy
Radiation therapy is often used to treat breast cancer after a tumor is removed. Traditionally, radiation has been given to a patient’s entire breast over about four to six weeks to increase the chance that any cancer cells remaining in the lumpectomy area are destroyed. Healthy cells, as well as cancer cells, can be affected by radiation. Partial breast irradiation, a newer technique, minimizes exposure to the rest of the breast, skin, ribs, lungs and heart. Partial breast irradiation treats only the immediate area surrounding the original tumor, where breast cancer is most likely to recur. Accelerated partial breast irradiation (APBI) delivers the equivalent of six weeks of daily radiation in just a few days.
Radiation Oncology
Philadelphia CyberKnife Receives Accreditation for SRS/SBRT Clinical Practice and Physics Quality Assurance The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, and the American College of Radiation Oncology (ACRO), the professional society for the practice of radiation oncology, today announced that the first center – Philadelphia CyberKnife…

Lesions
CyberKnife® robotic stereotactic radiosurgery (SRS) painlessly delivers precise beams of high-dose radiation to brain tumors and lesions, without incisions, hospitalization, or long recovery time. CyberKnife SRS is a non-invasive alternative to brain cancer surgery and can be used for brain tumors that are considered inoperable because of their location in the head, for those patients who cannot undergo brain cancer surgery due to their poor medical condition, or who refuse surgery. The CyberKnife System also can treat benign, or non-cancerous, tumors and other conditions, such as trigeminal neuralgia and arteriovenous malformations (AVMs).

View All Services

Provided by